@article{ref1,
title="The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study",
journal="Diabetes technology and therapeutics",
year="2014",
author="Esmatjes, E. and Jansà, M. and Roca, D. and Pérez-Ferre, N. and Del Valle, L. and Martínez-Hervás, S. and Ruiz De Adana, M. and Linares, F. and Batanero, R. and Vázquez, F. and Gomis, R. and De Solà-Morales, O. and Aguayo, A. and Castaño, L. and Gaztambide, S. and Vidal, M. and Calle, A. and Galindo, M. and Serrano-Ríos, M. and Federico, F.C.-s. and De Adana, M.R. and Rafael, C.",
volume="16",
number="7",
pages="435-441",
abstract="OBJECTIVE: This study evaluated the impact of an Internet-based telematic system on the economic and clinical management of patients with type 1 diabetes mellitus. Research Design and Methods: This 6-month prospective, randomized, comparative, open, multicenter study included patients with type 1 diabetes >18 years old treated with multiple insulin doses and with a glycated hemoglobin (HbA1c) level of >8%. We compared an intervention group (IG) (two face-to-face and five telematic appointments) with a control group (CG) (seven face-to-face appointments). The variables studied were (1) patient and healthcare team costs, (2) metabolic control, (3) knowledge of diabetes, (4) quality of life, and (5) self-care treatment adherence. <br><br>RESULTS: Of the 154 patients included, 118 (76.6%) completed the study (IG, 54; CG, 64). The time used by the CG to follow the program was 823±645min versus 353±222min in the IG (P<0.0001). Compared with the CG, the IG required less healthcare time from the professionals (288±105min vs. 232±89min; P<0.001). HbA1c improved in both groups (IG, 9.2±1.5% [77.0±17.0mmol/mol] vs. 8.7±1.5% [71.6±17.0mmol/mol] [P<0.001]; CG, 9.2±0.9% [77.0±10.0mmol/mol] vs. 8.6±0.9% [70.5±10.0mmol/mol] [P<0.001], as did knowledge and self-care treatment adherence. <br><br>CONCLUSIONS: The use of interactive telematic appointments in subjects with type 1 diabetes and inadequate metabolic control is an efficient strategy, providing results comparable to those of face-to-face appointments in relation to improvement in glycemic control, knowledge acquisition, and self-care treatment adherence, with a significant reduction in the time used, especially by patients. © Copyright 2014, Mary Ann Liebert, Inc. 2014.<p /><p>Language: en</p>",
language="en",
issn="1520-9156",
doi="10.1089/dia.2013.0313",
url="http://dx.doi.org/10.1089/dia.2013.0313"
}